Dr. Khaled Abdelrahman holds a BSc in Pharmaceutical Sciences and an MSc in Pharmacology from Alexandria University. He earned his PhD in 2015 from the University of Calgary, where he researched the molecular basis of altered cerebrovascular function in type 2 diabetes. Following his PhD, he joined the University of Ottawa’s Departments of Cellular & Molecular Medicine and Neuroscience to investigate novel G protein-coupled receptor (GPCR) candidates for pharmacological targeting to slow the progression of Alzheimer’s and Huntington’s diseases. During his postdoctoral tenure, Dr. Abdelrahman was supported by prestigious salary awards from Canadian Institutes of Health Research and Alberta Innovates. He also received the Canadian Society of Pharmacology and Therapeutics Postdoctoral Award and several young investigator awards from the American Society for Pharmacology and Experimental Therapeutics. With over 12 years of clinical experience, he is a registered pharmacist dedicated to providing patient care. Currently, Dr. Abdelrahman is an Assistant Professor in the Department of Anesthesiology, Pharmacology, and Therapeutics at the University of British Columbia (UBC) and a full member of the Djavad Mowafaghian Centre for Brain Health. Since joining UBC, he has been awarded the Michael Smith Health Research BC Health Investigator Award. His research program is supported by grants from the Alzheimer’s Society of Canada and the Canadian Institutes of Health Research.

Social Media / Lab or Research Website

Website: https://ksaresearch.med.ubc.ca/

Social Media: https://x.com/K_S_Abdelrahman

GPCRs, Neurodegeneration, Neurovascular Coupling, Cerebral Blood Flow

Research Theme(s)

Publication Link(s)

PubMed: https://pubmed.ncbi.nlm.nih.gov/?term=Khaled+abd-elrahman&sort=date

Google Scholar: https://scholar.google.ca/citations?hl=en&user=ArSK-kwAAAAJ

PCTH400, PCTH448E, PCTH548F, NRSC551